---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-005919"
form_type: "8-K"
ticker: "ACTU"
cik: "0001652935"
company_name: "ACTUATE THERAPEUTICS, INC."
filed_at: "2024-08-19T23:59:59+00:00"
generated_at: "2026-05-31T08:41:12.393602+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Actuate Therapeutics replaces auditor after KMJ joins Crowe; prior reports cite going concern and material weakness

## Summary
- KMJ Corbin & Company LLP resigned as auditor on Aug 19, 2024; Crowe LLP appointed same day.
- KMJ audit reports for FY2023 and FY2022 included a going-concern explanatory paragraph about substantial doubt.
- Company reported a material weakness in internal control over financial reporting due to inadequate review of clinical trial expense accruals.
- No disagreements between Company and KMJ on accounting principles or auditing scope.
- KMJ's professional staff joined Crowe LLP on May 20, 2024; change is related to that merger.

## SEC filing metadata
- accession: 0001683168-24-005919
- form_type: 8-K
- ticker: ACTU
- cik: 0001652935
- company_name: ACTUATE THERAPEUTICS, INC.
- filed_at: 2024-08-19T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1652935/000168316824005919/0001683168-24-005919-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1652935/000168316824005919/actuate_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-005919
- JSON: https://secwatch.observer/filing/0001683168-24-005919.json
- Plain text: https://secwatch.observer/filing/0001683168-24-005919.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.